CAPECITABINA GLENMARK 150mg film-coated tablets medication leaflet

L01BC06 • capecitabine • Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues

Capecitabine is a chemotherapy medication used to treat various types of cancer, including colon, rectal, breast, and stomach cancer. It is a prodrug, meaning it is converted in the body into its active form, 5-fluorouracil (5-FU), which interferes with DNA and RNA synthesis in cancer cells.

Capecitabine is taken orally in tablet form, making it more convenient than other forms of chemotherapy that require intravenous administration. Treatment is usually given in cycles, and the dosage is adjusted based on the patient's weight, overall health, and the type of cancer being treated.

The medication can be used alone or in combination with other chemotherapy drugs or targeted therapies. It is important for patients to strictly follow their doctor's instructions and report any side effects or unusual symptoms.

Common side effects include nausea, vomiting, diarrhea, fatigue, and hand-foot syndrome (redness, swelling, and pain in the palms and soles). In rare cases, more severe complications such as bone marrow suppression or cardiac toxicity may occur. Regular monitoring is essential to ensure the safety and effectiveness of the treatment.